Cancer News: Prostate
Prostate cancer patients with relatively unaggressive tumors survived without surgery or radiation, due to an active surveillance program, a new study proves.
Newly diagnosed patients with metastatic, hormone-sensitive prostate cancer survived longer when treated with a combination of two drugs, a new study reveals.
Increased radiation dose did not benefit low-risk prostate cancer patients, while it raised survival rates in medium and high-risk prostate cancer patients.
Watchful waiting or active surveillance may provide an alternative to prostate cancers patients keeping them away from the side effects of aggressive treatments.
The combination of adjuvant chemotherapy with androgen suppression and definitive radiation therapy extended overall survival in patients with high-risk prostate cancer.
An increasing body mass index (BMI) was associated with worse prostate cancer-specific outcomes in patients with localized prostate cancer, a new study reveals.
Age and body mass index and other gene factors associated with the hot flashes, men with prostate cancer experience when treated with androgen deprivation therapy.
Patients with gastrointestinal stromal tumors may develop additional malignancies before and after their diagnosis, according to the first population-based study.
Prostate cancer patients who receive permanent brachytherapy implants are twice as likely to be cancer-free after 5 years compared to external radiation.
Men with prostate cancer that had mutations in genes linked to repair of damaged DNA responded better to treatment with olaparib compared with patients who had disease without these mutations.
A new study shows that walking at an easy pace for only 3 hours every week is enough to help reduce the side effects of prostate cancer treatment.
Findings of two clinical trials overturn the widely accepted tactic of delaying radiation treatment to prostate cancer patients in order to reduce side effects.
Results from a population-based study show favorable survival outcomes among older patients with low-risk prostate cancer treated with conservative management.
Vitamin D can fight inflammation and improve the tumors of prostate cancer patients reducing the need for surgery or radiation, according to scientists.
Prostate cancer patients who smoke or have quit smoking less than 10 years previously, have twice the risk of a recurrence after surgery, according to new research.
Having first-degree relatives with a history of prostate cancer increases a woman’s risk of developing breast cancer, according to a new study.
Numerous latest findings in prostate cancer care were presented at the Genitourinary Cancers Symposium.
A study of 180,000 men indicates that men with history of testicular cancer have much higher risk of prostate cancer.
Men with intermediate-risk prostate cancer under active surveillance had significantly worse outcomes compared to those with low risk, according to a study.
Prostate cancer patients with detectable prostate specific antigen (PSA) after radical prostatectomy should receive earlier, more aggressive radiation treatment.
Prostate cancer drug abiraterone was found to significantly extend the lives of men with advanced prostate cancer if given before chemotherapy, in a trial.
Smokers with prostate cancer face increased risks of experiencing side effects from treatment and of developing future cancer recurrences.
Targeted MRI/ultrasound has been found to be more effective than standard biopsy in detecting high-risk prostate cancer in a large scale study.
In a surprising paradox during a trial, testosterone, generally thought to be a feeder of prostate cancer, was found to suppress some advanced prostate cancers.
Evaluating Sipuleucel-T, a prostate cancer drug, did not show proof of benefit in overall survival or patients’ health-related quality of life.
Hormone therapy plus radiation reduced cancer deaths by nearly 50% in older men with prostate cancer compared to patients who received hormone therapy alone.
A new study shows that prostate cancer patients with active lifestyles have better survival rate: walking or biking for 20+ minutes a day can make a difference.
In an analysis, patients who decide to monitor their prostate cancer with their doctors have equal/better wellbeing, compared to those who treat it immediately.
According to a new study, survivors of prostate cancer with higher levels of total cholesterol and triglycerides had an increased risk for disease recurrence.
Researchers analyzed the impact of prostate cancer treatment on urinary and sexual functioning to understand how each different option affects patients.